- Home
- ZIMV vs INM Comparison
ZIMV vs INM Comparison
Compare ZIMV & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- INM
- Stock Information
- Founded
- ZIMV 2021
- INM 1981
- Country
- ZIMV United States
- INM Canada
- Employees
- ZIMV N/A
- INM N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ZIMV Health Care
- INM Health Care
- Exchange
- ZIMV Nasdaq
- INM Nasdaq
- Market Cap
- ZIMV 262.9M
- INM 3.2M
- IPO Year
- ZIMV N/A
- INM N/A
- Fundamental
- Price
- ZIMV $9.42
- INM $2.98
- Analyst Decision
- ZIMV Hold
- INM
- Analyst Count
- ZIMV 1
- INM 0
- Target Price
- ZIMV N/A
- INM N/A
- AVG Volume (30 Days)
- ZIMV 142.8K
- INM 55.8K
- Earning Date
- ZIMV 05-07-2025
- INM 05-13-2025
- Dividend Yield
- ZIMV N/A
- INM N/A
- EPS Growth
- ZIMV N/A
- INM N/A
- EPS
- ZIMV N/A
- INM N/A
- Revenue
- ZIMV $449,749,000.00
- INM $4,832,013.00
- Revenue This Year
- ZIMV $1.90
- INM N/A
- Revenue Next Year
- ZIMV $2.61
- INM N/A
- P/E Ratio
- ZIMV N/A
- INM N/A
- Revenue Growth
- ZIMV N/A
- INM N/A
- 52 Week Low
- ZIMV $8.56
- INM $1.72
- 52 Week High
- ZIMV $22.40
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ZIMV 38.19
- INM 60.92
- Support Level
- ZIMV $8.75
- INM $2.56
- Resistance Level
- ZIMV $9.74
- INM $3.15
- Average True Range (ATR)
- ZIMV 0.64
- INM 0.28
- MACD
- ZIMV 0.10
- INM 0.09
- Stochastic Oscillator
- ZIMV 52.44
- INM 88.11
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.